Using hyperpolarized 3He MRI to evaluate treatment efficacy in cystic fibrosis patients

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 5, 2011, Pages 1206-1211

  Sun, Yanping ^a,b   O'Sullivan, Brian P ^a   Roche, John P ^a,c   Walvick, Ronn ^a   Reno, Austin ^a   Baker, Dawn ^a   Mansour, Joey K ^a   Albert, Mitchell S ^a,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Thunder Bay Regional Research Institute   (Canada)

Author keywords

cystic fibrosis; hyperpolarized gas MRI; MRI; pulmonary function

Indexed keywords

BETA LACTAM; TOBRAMYCIN; DEOXYRIBONUCLEASE; HELIUM;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CYSTIC FIBROSIS; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HELIUM NUCLEAR MAGNETIC RESONANCE IMAGING; HUMAN; LUNG VENTILATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIROMETRY; CHEMISTRY; FEMALE; GAS; LUNG; LUNG FUNCTION TEST; MALE; METHODOLOGY; PATHOLOGY; VITAL CAPACITY;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; DEOXYRIBONUCLEASES; FEMALE; FORCED EXPIRATORY VOLUME; GASES; HELIUM; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MALE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; VITAL CAPACITY;

EID: 80054759048     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22724     Document Type: Article

References (33)

1. O'Sullivan BP, Freedman SD,. Cystic fibrosis. Lancet 2009; 373: 1891-1904.
2. Ashlock MA, Beall RJ, Hamblett NM, et al. A pipeline of therapies for cystic fibrosis. Semin Respir Crit Care Med 2009; 30: 611-626.
3. Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009; 180: 802-808.
4. Johnson JC, Clifford JC, Guo J, Dhand R,. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer. Respir Care 2008; 53: 1703-1708.
5. Krämer I, Schwabe A, Lichtinghagen R, Kamin W,. Physicochemical compatibility of mixtures of dornase alfa and tobramycin containing nebulizer solutions. Pediatr Pulmonol 2009; 44: 134-141.
6. Lands LC, Milner R, Cantin AM, Manson D, Corey M,. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. J Pediatr 2007; 151: 249-254. (Pubitemid 47284135)
7. Altes TA, Eichinger M, Puderbach M,. Magnetic resonance imaging of the lung in cystic fibrosis. Proc Am Thorac Soc 2007; 4: 321-327. (Pubitemid 47330864)
8. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004; 23: 93-97. (Pubitemid 38088503)
9. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006; 61: 80-85. (Pubitemid 43106983)
10. Tiddens HA, de Jong PA,. Imaging and clinical trials in cystic fibrosis. Proc Am Thorac Soc 2007; 4: 343-346. (Pubitemid 47330868)
11. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med 2006; 173: 199-203. (Pubitemid 43187892)
12. Brody AS, Tiddens HA, Castile RG, et al. CT Scanning in Cystic Fibrosis Special Interest Group. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 2005; 172: 1246-1252. (Pubitemid 43076562)
13. de Jong PA, Nakano Y, Lequin MH, Tiddens HA,. Dose reduction for CT in children with cystic fibrosis: is it feasible to reduce the number of images per scan? Pediatr Radiol 2006; 36: 50-53. (Pubitemid 43280449)
14. van Beek EJ, Hill C, Woodhouse N, et al. Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry. Eur Radiol 2007; 17: 1018-1024. (Pubitemid 46766883)
15. McMahon CJ, Dodd JD, Hill C, et al. Hyperpolarized 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: comparison with high resolution CT and spirometry. Eur Radiol 2006; 16: 2483-2490. (Pubitemid 44649697)
16. Eichinger M, Heussel CP, Kauczor HU, Tiddens H, Puderbach M,. Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease. J Magn Reson Imaging 2010; 32: 1370-1378.
17. Albert MS, Cates GD, Driehuys B, et al. Biological magnetic resonance imaging using hyperpolarized 129Xe. Nature 1994; 370: 199.
18. Fain S, Schiebler ML, McCormack DG, Parraga G,. Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: review of current and emerging translational methods and applications. J Magn Reson Imaging 2010; 32: 1398-1408.
19. Puderbach M, Eichinger M,. The role of advanced imaging techniques in cystic fibrosis follow-up: is there a place for MRI? Pediatr Radiol 2010; 40: 844-849.
20. van Beek EJ, Dahmen AM, Stavngaard T, et al. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 2009; 34: 1311-1321.
21. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284. (Pubitemid 350190758)
22. Brody AS, Frush DP, Huda W, Brent RL,; American Academy of Pediatrics, Section on Radiology. Radiation risk to children from computed tomography. Pediatrics 2007; 120: 677-682. (Pubitemid 47358314)
23. Chodick G, Kim KP, Shwarz M, Horev G, Shalev V, Ron E,. Radiation risks from pediatric computed tomography scanning. Pediatr Endocrinol Rev 2009; 7: 109-116.
24. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005; 21: 365-369. (Pubitemid 40446430)
25. Tzeng YS, Lutchen K, Albert M,. The difference in ventilation heterogeneity between asthmatic and healthy subjects quantified using hyperpolarized 3He MRI. J Appl Physiol 2009; 106: 813-822.
26. Mayer-Hamblett N, Ramsey BW, Kronmal RA,. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thorac Soc 2007; 4: 370-377. (Pubitemid 47330874)
27. Donnelly LF, MacFall JR, McAdams HP, et al. Cystic fibrosis: combined hyperpolarized 3He-enhanced and conventional proton MR imaging in the lung-preliminary observations. Radiology 1999; 212: 885-889. (Pubitemid 29410997)
28. Woodhouse N, Wild JM, van Beek EJ, Hoggard N, Barker N, Taylor CJ,. Assessment of hyperpolarized 3He lung MRI for regional evaluation of interventional therapy: a pilot study in pediatric cystic fibrosis. J Magn Reson Imaging 2009; 30: 981-988.
29. Bannier E, Cieslar K, Mosbah K, et al. Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology 2010; 255: 225-232.
30. Maffessanti M, Candusso M, Brizzi F, Piovesana F,. Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996; 11: 27-38. (Pubitemid 126443567)
31. Meyer KC, Sharma A,. Regional variability of lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 1536-1540. (Pubitemid 27505521)
32. Mentore K, Froh DK, de Lange EE, Brookeman JR, Paget-Brown AO, Altes TA,. Hyperpolarized He 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005; 12: 1423-1429. (Pubitemid 41512835)
33. Lee EY, Sun Y, Zurakowski D, Hatabu H, Khatwa U, Albert MS,. Hyperpolarized 3He MR imaging of the lung: normal range of ventilation defects and PFT correlation in young adults. J Thorac Imaging 2009; 24: 110-114.